Arlene Ash to Costs and Cost Analysis
This is a "connection" page, showing publications Arlene Ash has written about Costs and Cost Analysis.
Connection Strength
0.462
-
Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care. 2008 Aug; 46(8):839-46.
Score: 0.300
-
Yu W, Ellis RP, Ash A. Risk selection in the Massachusetts State employee health insurance program. Health Care Manag Sci. 2001 Dec; 4(4):281-7.
Score: 0.047
-
Ellis RP, Ash A. Refinements to the Diagnostic Cost Group (DCG) model. Inquiry. 1995-1996 Winter; 32(4):418-29.
Score: 0.029
-
Rose AJ, Berlowitz DR, Ash AS, Ozonoff A, Hylek EM, Goldhaber-Fiebert JD. The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):416-24.
Score: 0.023
-
Ash A, Porell F, Gruenberg L, Sawitz E, Beiser A. Adjusting Medicare capitation payments using prior hospitalization data. Health Care Financ Rev. 1989; 10(4):17-29.
Score: 0.019
-
Iezzoni LI, Ash AS, Cobb JL, Moskowitz MA. Admission MedisGroups score and the cost of hospitalizations. Med Care. 1988 Nov; 26(11):1068-80.
Score: 0.019
-
Kronman AC, Ash AS, Freund KM, Hanchate A, Emanuel EJ. Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med. 2008 Sep; 23(9):1330-5.
Score: 0.019
-
Iezzoni LI, Shwartz M, Moskowitz MA, Ash AS, Sawitz E, Burnside S. Illness severity and costs of admissions at teaching and nonteaching hospitals. JAMA. 1990 Sep 19; 264(11):1426-31.
Score: 0.005